Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 0

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 0
---
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-276248

PROSPECTUS SUPPLEMENT

(To prospectus dated April 4, 2024)

<div align='center'>2,000,000 Shares

8.00% Series B Cumulative Redeemable Preferred Stock</div>

Global Medical REIT Inc. (“we,” “us,”
“our” or the “Company”) is an internally-managed real estate investment trust (“REIT”) that acquires
healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. We are selling 2,000,000
shares of our 8.00% Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”),
in this offering. This is the original issuance of shares of our Series B Preferred Stock, which will have a liquidation preference
of $25.00 per share.

Holders of Series B Preferred Stock will
be entitled to receive dividend payments only when, as and if declared by the board of directors of the Company (the “Board of Directors”)
or a duly authorized committee of the Board of Directors. Any such dividends will be payable in cash from the original issuance date on
a cumulative basis, quarterly in arrears on January 31, April 30, July 31 and October 31 of each year, commencing
on January 31, 2026 to holders of record as of January 15, 2026. The dividend rate of 8.00% per annum will be applied to the
liquidation preference of $25.00 per share (equivalent to $2.00 per share per annum). Payment of dividends on the Series B Preferred
Stock is subject to certain legal and other restrictions as described elsewhere in this prospectus supplement.

We may, at our option, redeem the Series B
Preferred Stock for cash in whole or in part, from time to time, at any time on or after November 20, 2030, as described under “Description
of Series B Preferred Stock — Redemption — Redemption at Our Option,” at a cash redemption price of $25.00 per
share, plus any accrued and unpaid dividends up to, but not including, the date of redemption. In addition, upon the occurrence of a Change
of Control (as defined herein), as a result of which, except for limited circumstances described herein, neither we nor the acquiring